Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase I Open Label Non-comparative Study Evaluating the Safety of a Single, Unilateral, Subretinal Administration of CNTO 2476 in Advanced Retinitis Pigmentosa

NCT00458575 is registered in ClinicalTrials.gov with Centocor, Inc. as lead sponsor.

NCT NCT00458575
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00458575 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase I Open Label Non-comparative Study Evaluating the Safety of a Single, Unilateral, Subretinal Administration of CNTO 2476 in Advanced Retinitis Pigmentosa
Lead sponsor
Centocor, Inc.
Phase
Phase 1
Overall status
Terminated
Start date
April 30, 2007
Completion date
August 31, 2013
Enrollment
7 (actual)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

retinitis pigmentosa